Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4148

TDMS Study 93023-06 Pathology Tables

NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01
Route: GAVAGE                                                                                                     Time: 15:11:34

                                                          FINAL#1/RATS




       Facility:  Southern Research Institute

       Chemical CAS #:  142-83-6

       Lock Date:  02/28/00

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                12            9            6            9                                     
    Natural Death                                      1            1            2            4                                     
    Dosing Accident                                                 1            1            6                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           38           41           31                                     
    Natural Death                                                   1                                                               
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (48)         (47)         (50)         (48)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
      Perforation                                                                             1 (2%)                                
   Intestine Large, Cecum                             (50)         (50)         (50)         (50)                                   
      Edema                                                         1 (2%)                    2 (4%)                                
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Basophilic Focus                                47 (94%)     49 (98%)     48 (96%)     45 (90%)                               
      Clear Cell Focus                                 7 (14%)      8 (16%)     11 (22%)      4 (8%)                                
      Eosinophilic Focus                               9 (18%)     10 (20%)      6 (12%)      4 (8%)                                
      Hepatodiaphragmatic Nodule                       9 (18%)      6 (12%)      6 (12%)      4 (8%)                                
      Infiltration Cellular, Mixed Cell               15 (30%)     10 (20%)     10 (20%)     17 (34%)                               
      Mixed Cell Focus                                 6 (12%)     12 (24%)      6 (12%)      9 (18%)                               
      Bile Duct, Hyperplasia                           5 (10%)                                1 (2%)                                
      Hepatocyte, Cytomegaly                           2 (4%)                                 1 (2%)                                
      Hepatocyte, Necrosis                             2 (4%)                    1 (2%)       3 (6%)                                
      Hepatocyte, Vacuolization Cytoplasmic            1 (2%)       3 (6%)                    1 (2%)                                
      Kupffer Cell, Pigmentation                       2 (4%)       3 (6%)                    1 (2%)                                
   Mesentery                                          (13)         (16)         (19)         (15)                                   
      Fat, Necrosis                                   13 (100%)    16 (100%)    18 (95%)     15 (100%)                              
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                          7 (14%)     12 (24%)      8 (16%)      8 (16%)                               
      Cyst                                             2 (4%)       4 (8%)       1 (2%)       3 (6%)                                
      Acinus, Cytoplasmic Alteration                   1 (2%)       2 (4%)                    2 (4%)                                
      Acinus, Hyperplasia, Focal                       3 (6%)       2 (4%)       2 (4%)       1 (2%)                                
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                                       2 (4%)       5 (10%)      4 (8%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Necrosis                                                      1 (2%)                                                          
   Stomach, Forestomach                               (50)         (49)         (50)         (50)                                   
      Edema                                            1 (2%)       1 (2%)                    2 (4%)                                
      Erosion                                          1 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)       2 (4%)                                
      Ulcer                                            1 (2%)                                 1 (2%)                                
      Epithelium, Cyst                                                                        1 (2%)                                
      Epithelium, Hyperplasia                          2 (4%)      16 (33%)     37 (74%)     41 (82%)                               
   Stomach, Glandular                                 (50)         (49)         (50)         (50)                                   
      Edema                                            1 (2%)                                                                       
      Erosion                                                                                 1 (2%)                                
      Ulcer                                                                      1 (2%)       1 (2%)                                
   Tongue                                             (1)                       (2)          (1)                                    
      Hyperplasia                                      1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  20 (40%)     20 (40%)     17 (34%)     13 (26%)                               
      Myocardium, Necrosis                                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule               13 (26%)     13 (26%)     13 (26%)     13 (26%)                               
      Angiectasis                                      3 (6%)       2 (4%)       1 (2%)       2 (4%)                                
      Degeneration, Fatty                             12 (24%)     11 (22%)     11 (22%)     11 (22%)                               
      Hyperplasia, Diffuse                             2 (4%)                    1 (2%)       1 (2%)                                
      Hyperplasia, Focal                               3 (6%)       6 (12%)      5 (10%)      4 (8%)                                
      Hypertrophy, Focal                               9 (18%)      9 (18%)      8 (16%)      5 (10%)                               
      Necrosis                                                                                2 (4%)                                
   Adrenal Medulla                                    (50)         (49)         (50)         (50)                                   
      Hyperplasia                                      3 (6%)       1 (2%)       1 (2%)       1 (2%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       2 (4%)       1 (2%)                                             
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Pars Distalis, Angiectasis                       9 (18%)      3 (6%)       5 (10%)      2 (4%)                                
      Pars Distalis, Cyst                             22 (44%)     14 (28%)     12 (24%)     15 (30%)                               
      Pars Distalis, Hyperplasia                                    3 (6%)       1 (2%)                                             
      Pars Distalis, Hyperplasia, Focal               13 (26%)      8 (16%)      7 (14%)      9 (18%)                               
      Pars Intermedia, Angiectasis                                               1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Intermedia, Cyst                                         1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Ultimobranchial Cyst                                          2 (4%)                    2 (4%)                                
      C-Cell, Hyperplasia                             24 (48%)     22 (44%)     26 (52%)     14 (28%)                               
      Follicle, Cyst                                                1 (2%)       1 (2%)                                             
      Follicular Cell, Hyperplasia                                                            1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (50)         (50)         (50)                                   
      Cyst                                             8 (16%)      6 (12%)      2 (4%)       2 (4%)                                
      Hyperplasia                                      1 (2%)                                 1 (2%)                                
      Inflammation, Chronic                            1 (2%)       6 (12%)      3 (6%)       5 (10%)                               
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Cyst                                            12 (24%)      7 (14%)      8 (16%)      9 (18%)                               
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Hydrometra                                       2 (4%)       7 (14%)      6 (12%)      2 (4%)                                
      Hyperplasia, Cystic                              3 (6%)       4 (8%)       4 (8%)       5 (10%)                               
      Inflammation, Chronic                                                      1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)       5 (10%)      5 (10%)      2 (4%)                                
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
   Lymph Node                                         (29)         (30)         (30)         (38)                                   
      Deep Cervical, Hemorrhage                        1 (3%)       1 (3%)       1 (3%)       1 (3%)                                
      Deep Cervical, Hyperplasia, Lymphoid                                                    1 (3%)                                
      Deep Cervical, Pigmentation                      1 (3%)       1 (3%)       1 (3%)       1 (3%)                                
      Mediastinal, Hemorrhage                                       3 (10%)      4 (13%)      2 (5%)                                
      Mediastinal, Hyperplasia, Lymphoid               5 (17%)      8 (27%)     10 (33%)      3 (8%)                                
      Mediastinal, Pigmentation                        4 (14%)      8 (27%)      7 (23%)      3 (8%)                                
      Pancreatic, Hemorrhage                           8 (28%)      8 (27%)     13 (43%)     17 (45%)                               
      Pancreatic, Hyperplasia                          1 (3%)                                                                       
      Pancreatic, Hyperplasia, Lymphoid               17 (59%)     24 (80%)     18 (60%)     28 (74%)                               
      Pancreatic, Pigmentation                        24 (83%)     25 (83%)     24 (80%)     32 (84%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Lymph Node, Mandibular                             (6)          (2)          (5)          (1)                                    
      Ectasia                                          2 (33%)      1 (50%)      2 (40%)                                            
      Hyperplasia, Lymphoid                            1 (17%)                                                                      
      Pigmentation                                     3 (50%)      1 (50%)                                                         
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                      10 (20%)      6 (12%)      3 (6%)       4 (8%)                                
      Hyperplasia, Lymphoid                            9 (18%)     17 (34%)     15 (30%)     13 (26%)                               
      Pigmentation                                    42 (84%)     42 (84%)     33 (66%)     34 (68%)                               
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Fibrosis                                                                                2 (4%)                                
      Hematopoietic Cell Proliferation                34 (68%)     26 (52%)     29 (58%)     21 (42%)                               
      Infiltration Cellular, Mixed Cell                                                       1 (2%)                                
      Pigmentation                                    29 (58%)     34 (68%)     35 (70%)     36 (72%)                               
      Lymphoid Follicle, Atrophy                                                              4 (8%)                                
      Lymphoid Follicle, Hyperplasia                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     43 (86%)     47 (94%)     48 (96%)     40 (80%)                               
      Hyperplasia, Lobular                             2 (4%)                                                                       
   Skin                                               (49)         (49)         (50)         (50)                                   
      Inflammation, Chronic                                                                   1 (2%)                                
      Subcutaneous Tissue, Edema                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Femur, Osteopetrosis                             2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression                                      7 (14%)     12 (24%)      6 (12%)      8 (16%)                               
      Hydrocephalus                                    3 (6%)       8 (16%)      2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Congestion                                       1 (2%)       2 (4%)       2 (4%)       7 (14%)                               
      Edema                                                         2 (4%)       3 (6%)       7 (14%)                               
      Foreign Body                                                  1 (2%)       1 (2%)                                             
      Hemorrhage                                                                 1 (2%)       4 (8%)                                
      Infiltration Cellular, Histiocyte               41 (82%)     41 (82%)     41 (82%)     43 (86%)                               
      Inflammation, Granulomatous                                   1 (2%)       1 (2%)                                             
      Metaplasia, Osseous                              1 (2%)       2 (4%)                                                          
      Alveolar Epithelium, Hyperplasia                 2 (4%)       6 (12%)      7 (14%)      5 (10%)                               
      Alveolar Epithelium, Hyperplasia, Multifocal     1 (2%)                                                                       
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     2 (4%)                    3 (6%)       2 (4%)                                
      Inflammation, Chronic                            4 (8%)       3 (6%)       4 (8%)       4 (8%)                                
      Respiratory Epithelium, Hyperplasia              3 (6%)       1 (2%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)                       (3)          (1)                                    
      Cataract                                         1 (100%)                  3 (100%)     1 (100%)                              
      Retina, Degeneration                             1 (100%)                  3 (100%)     1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                          1 (2%)                    1 (2%)                                
      Hydronephrosis                                                                          2 (4%)                                
      Inflammation, Chronic                                         2 (4%)                                                          
      Nephropathy                                      2 (4%)       6 (12%)      6 (12%)      6 (12%)                               
      Renal Tubule, Cytoplasmic Alteration             3 (6%)       4 (8%)       5 (10%)      4 (8%)                                
      Renal Tubule, Dilatation                                                   1 (2%)                                             
      Renal Tubule, Infarct                                                                   1 (2%)                                
      Renal Tubule, Necrosis                                        1 (2%)                    2 (4%)                                
      Renal Tubule, Pigmentation                       4 (8%)       2 (4%)       3 (6%)       8 (16%)                               
      Transitional Epithelium, Hyperplasia                          1 (2%)       1 (2%)       1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic                                         1 (2%)                                                          
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                10           11           13           10                                     
    Dosing Accident                                    1            2            1            5                                     
    Natural Death                                      2            2            3            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           35           33           30                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (49)         (48)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Perforation                                      1 (2%)       1 (2%)       1 (2%)                                             
   Intestine Large, Cecum                             (50)         (50)         (50)         (50)                                   
      Edema                                                                      1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                33 (66%)     32 (64%)     31 (62%)     23 (46%)                               
      Clear Cell Focus                                 7 (14%)      6 (12%)      8 (16%)      7 (14%)                               
      Degeneration, Cystic                             1 (2%)       1 (2%)                                                          
      Eosinophilic Focus                               4 (8%)       9 (18%)     10 (20%)      5 (10%)                               
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Hepatodiaphragmatic Nodule                       2 (4%)       7 (14%)      3 (6%)       6 (12%)                               
      Infiltration Cellular, Mixed Cell                5 (10%)      2 (4%)       1 (2%)       3 (6%)                                
      Mixed Cell Focus                                 7 (14%)      7 (14%)     10 (20%)      2 (4%)                                
      Bile Duct, Hyperplasia                          25 (50%)     34 (68%)     39 (78%)     15 (30%)                               
      Centrilobular, Necrosis                          1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Hepatocyte, Vacuolization Cytoplasmic            1 (2%)       9 (18%)      6 (12%)      1 (2%)                                
      Kupffer Cell, Pigmentation                                    1 (2%)                    1 (2%)                                
   Mesentery                                          (13)         (8)          (19)         (17)                                   
      Accessory Spleen                                 2 (15%)      1 (13%)      1 (5%)       2 (12%)                               
      Hemorrhage                                       1 (8%)                                 1 (6%)                                
      Fat, Necrosis                                   11 (85%)      7 (88%)     17 (89%)     14 (82%)                               
   Oral Mucosa                                        (1)          (1)          (1)          (1)                                    
      Hyperplasia                                                   1 (100%)                                                        
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                         16 (32%)     14 (28%)      7 (14%)     13 (26%)                               
      Cyst                                             2 (4%)       3 (6%)       2 (4%)       2 (4%)                                
      Acinus, Cytoplasmic Alteration                   3 (6%)       2 (4%)       3 (6%)       2 (4%)                                
      Acinus, Hyperplasia, Focal                      17 (34%)     13 (26%)     18 (36%)     12 (24%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          3 (6%)       1 (2%)                    1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Edema                                                         2 (4%)       2 (4%)                                             
      Erosion                                                                                 1 (2%)                                
      Inflammation, Chronic Active                                               1 (2%)       6 (12%)                               
      Ulcer                                            1 (2%)                                                                       
      Epithelium, Cyst                                                           1 (2%)       5 (10%)                               
      Epithelium, Hyperplasia                          3 (6%)      19 (38%)     42 (84%)     50 (100%)                              
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Edema                                                                      1 (2%)                                             
      Erosion                                          1 (2%)       1 (2%)                    2 (4%)                                
      Ulcer                                            1 (2%)       1 (2%)       1 (2%)                                             
   Tongue                                             (2)          (1)          (2)          (1)                                    
      Hyperplasia                                                                             1 (100%)                              
      Epithelium, Hyperplasia                          2 (100%)                  1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  36 (72%)     40 (80%)     42 (84%)     40 (80%)                               
      Inflammation, Suppurative                                                               1 (2%)                                
      Thrombosis                                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule               18 (36%)     21 (42%)     17 (34%)     17 (34%)                               
      Angiectasis                                                   1 (2%)       1 (2%)       2 (4%)                                
      Degeneration, Fatty                             12 (24%)      8 (16%)     10 (20%)     11 (22%)                               
      Hyperplasia, Diffuse                             1 (2%)                    2 (4%)       1 (2%)                                
      Hyperplasia, Focal                               1 (2%)       2 (4%)       6 (12%)      6 (12%)                               
      Hypertrophy, Focal                               5 (10%)      3 (6%)       5 (10%)      8 (16%)                               
      Metaplasia, Osseous                                           1 (2%)                                                          
   Adrenal Medulla                                    (50)         (49)         (50)         (49)                                   
      Hyperplasia                                      7 (14%)     10 (20%)      6 (12%)      5 (10%)                               
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)                                                                       
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Cyst                                                                                    1 (2%)                                
      Pars Distalis, Angiectasis                       3 (6%)       4 (8%)       1 (2%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Cyst                              4 (8%)       1 (2%)       6 (12%)      8 (16%)                               
      Pars Distalis, Hyperplasia                                                              2 (4%)                                
      Pars Distalis, Hyperplasia, Focal                8 (16%)      8 (16%)      9 (18%)      9 (18%)                               
      Pars Intermedia, Angiectasis                                               2 (4%)       2 (4%)                                
      Pars Intermedia, Cyst                                                      1 (2%)       4 (8%)                                
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      C-Cell, Hyperplasia                             26 (52%)     16 (32%)     18 (36%)     10 (20%)                               
      Follicle, Cyst                                   1 (2%)                    2 (4%)                                             
      Follicular Cell, Hyperplasia                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Atypia Cellular                                 35 (70%)     36 (72%)     28 (56%)     37 (74%)                               
   Preputial Gland                                    (49)         (50)         (50)         (50)                                   
      Cyst                                             1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
      Inflammation, Chronic                           21 (43%)     21 (42%)     31 (62%)     24 (48%)                               
   Prostate                                           (49)         (47)         (50)         (50)                                   
      Inflammation, Chronic                           15 (31%)     17 (36%)     17 (34%)     13 (26%)                               
      Epithelium, Hyperplasia                                                                 3 (6%)                                
      Epithelium, Ventral, Degeneration                3 (6%)                                 1 (2%)                                
      Epithelium, Ventral, Hyperplasia                12 (24%)      9 (19%)     11 (22%)     10 (20%)                               
      Ventral, Inflammation                            3 (6%)                                 1 (2%)                                
   Testes                                             (50)         (50)         (50)         (50)                                   
      Germinal Epithelium, Atrophy                     8 (16%)      9 (18%)     11 (22%)      5 (10%)                               
      Interstitial Cell, Hyperplasia                   8 (16%)      7 (14%)      7 (14%)      5 (10%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      4 (8%)       3 (6%)       6 (12%)      4 (8%)                                
   Lymph Node                                         (21)         (27)         (29)         (28)                                   
      Deep Cervical, Hyperplasia, Lymphoid                                                    1 (4%)                                
      Iliac, Pigmentation                                           1 (4%)                                                          
      Mediastinal, Ectasia                             1 (5%)                                 1 (4%)                                
      Mediastinal, Hemorrhage                          3 (14%)      1 (4%)       4 (14%)                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Hyperplasia, Lymphoid               5 (24%)      4 (15%)      4 (14%)      4 (14%)                               
      Mediastinal, Pigmentation                        3 (14%)                   5 (17%)                                            
      Pancreatic, Ectasia                                                        1 (3%)       2 (7%)                                
      Pancreatic, Hemorrhage                           8 (38%)      9 (33%)     11 (38%)     11 (39%)                               
      Pancreatic, Hyperplasia, Lymphoid                8 (38%)     14 (52%)     15 (52%)     16 (57%)                               
      Pancreatic, Pigmentation                        12 (57%)     18 (67%)     22 (76%)     23 (82%)                               
   Lymph Node, Mandibular                             (8)          (1)          (3)          (2)                                    
      Ectasia                                          1 (13%)                   1 (33%)                                            
      Hyperplasia, Lymphoid                            1 (13%)                                                                      
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Ectasia                                                       2 (4%)                    1 (2%)                                
      Hemorrhage                                      14 (28%)      8 (16%)      5 (10%)      4 (8%)                                
      Hyperplasia, Lymphoid                           16 (32%)      9 (18%)     22 (44%)     22 (44%)                               
      Pigmentation                                    43 (86%)     32 (64%)     31 (62%)     21 (42%)                               
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Fibrosis                                         2 (4%)                    1 (2%)       1 (2%)                                
      Hematopoietic Cell Proliferation                20 (40%)     20 (40%)     22 (44%)     14 (28%)                               
      Pigmentation                                     7 (14%)      9 (18%)     18 (36%)     20 (40%)                               
      Lymphoid Follicle, Atrophy                                                              3 (6%)                                
      Lymphoid Follicle, Hyperplasia                                1 (2%)       1 (2%)       1 (2%)                                
   Thymus                                             (50)         (49)         (50)         (49)                                   
      Hemorrhage                                       1 (2%)       1 (2%)                    2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (45)         (46)         (44)                                   
      Cyst                                                                       1 (2%)                                             
      Hyperplasia                                     13 (27%)     12 (27%)     14 (30%)     10 (23%)                               
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                  2 (4%)       2 (4%)                                
      Foreign Body                                     1 (2%)                                                                       
      Granuloma                                                                  1 (2%)                                             
      Hyperkeratosis                                                                          1 (2%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Ulcer                                                                                   2 (4%)                                
      Epidermis, Hyperplasia                           1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Cranium, Osteopetrosis                           1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression                                      7 (14%)      3 (6%)       6 (12%)      3 (6%)                                
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hydrocephalus                                    3 (6%)       2 (4%)       1 (2%)       3 (6%)                                
      Necrosis                                         1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)       1 (2%)       2 (4%)       3 (6%)                                
      Edema                                            3 (6%)       1 (2%)       1 (2%)       5 (10%)                               
      Foreign Body                                     1 (2%)                                                                       
      Hemorrhage                                       4 (8%)       3 (6%)       1 (2%)       4 (8%)                                
      Infiltration Cellular, Histiocyte               33 (66%)     25 (50%)     19 (38%)     27 (54%)                               
      Inflammation, Granulomatous                                                             1 (2%)                                
      Inflammation, Suppurative                                     1 (2%)                    1 (2%)                                
      Metaplasia, Osseous                              1 (2%)                    2 (4%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 7 (14%)      4 (8%)       5 (10%)      6 (12%)                               
      Alveolar Epithelium, Hyperplasia, Focal                                    1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     5 (10%)      6 (12%)      5 (10%)      2 (4%)                                
      Inflammation, Chronic                            9 (18%)     10 (20%)     12 (24%)      8 (16%)                               
      Olfactory Epithelium, Atrophy                                                           2 (4%)                                
      Respiratory Epithelium, Hyperplasia              2 (4%)       7 (14%)      7 (14%)      1 (2%)                                
      Respiratory Epithelium, Metaplasia, Squamous                  3 (6%)       2 (4%)                                             
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Epithelium, Hyperplasia                                       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (2)                       (3)                                    
      Cataract                                         1 (100%)     2 (100%)                  2 (67%)                               
      Hemorrhage                                                                              1 (33%)                               
      Inflammation, Chronic                                                                   1 (33%)                               
      Retina, Degeneration                             1 (100%)     2 (100%)                  1 (33%)                               
   Harderian Gland                                                              (1)          (1)                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 03/14/01    
Route: GAVAGE                                                                                                     Time: 15:11:34    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0            22.5         45           90                                        
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Pigmentation                                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                                       1 (2%)       1 (2%)                                
      Glomerulosclerosis                                                                      1 (2%)                                
      Hydronephrosis                                   1 (2%)       1 (2%)                                                          
      Infarct                                                       1 (2%)                                                          
      Inflammation, Chronic                            3 (6%)       3 (6%)       2 (4%)       2 (4%)                                
      Nephropathy                                     28 (56%)     22 (44%)     19 (38%)     19 (38%)                               
      Renal Tubule, Cytoplasmic Alteration                                                    2 (4%)                                
      Renal Tubule, Dilatation                         1 (2%)       1 (2%)       2 (4%)                                             
      Renal Tubule, Necrosis                           1 (2%)       1 (2%)                                                          
      Renal Tubule, Pigmentation                                                 1 (2%)       3 (6%)                                
      Transitional Epithelium, Hyperplasia                          2 (4%)                    1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Edema                                                         1 (2%)                                                          
      Hemorrhage                                       1 (2%)       2 (4%)                    1 (2%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                          2 (4%)                                                          
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------